NuPathe, Inc. (PATH) Posts Narrower than Expected Loss of 38c/Share

NuPathe, Inc. (NASDAQ: PATH) reported Q4 EPS of ($0.38), $0.12 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on NuPathe, Inc. (PATH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Investing.com’s stocks of the week
• Stellantis NV (STLA) PT Lowered to $7.50 at Freedom Broker
• Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c